Development of Gene Delivery Systems to Intestinal Epithelial Cells as a Target

以肠上皮细胞为靶标的基因传递系统的开发

基本信息

  • 批准号:
    09672324
  • 负责人:
  • 金额:
    $ 2.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

In the present study, the secretion polarity of interferon (IFN)-beta exogenously expressed following transfection of mouse or human IFN-beta expression plasmid in four kinds of epithelial cells was studied using a bicameral culture system : human colorectal carcinoma Caco-2, mouse squamous cell carcinoma Pam-T, Mardin-Darby canine kidney MDCK, and porcine tubular epithelial cell LLC-PK1 I_n the former three kinds, transiently expressed IFN-beta was predominantly secreted from the cell membrane side to which the transfection was carried out ; if the plasmid was applied to the upper or lower compartment, IFN-beta was secreted from the apical or basolateral membrane, respectively. Interestingly, simultaneous transfection from both sides, apically with mouse IFN-beta gene and basally with human LFN-betag ene, resulted in mouse IFN-beta secretion into upper compartments and human IFN-beta secretion into lower compartments, and vice versa. LLC-PK_1 cells showed non-polarized transient secretion. Meanwhile, stable secretion from the transformants, which is established from either cell line transfected with IFN-beta expression plasmid was non-polarized. Taken together these results suggest that epithelial cells have various protein sorting-secretion pathways for the same protein. The sorting manner seems to be depended on how the protein is expressed, constitutive oremergent. These findings would be useful to construct the strategy for gene transfer into intestinal epithelial cells and other polarized cells.
在本研究中,使用双室培养系统研究了在四种上皮细胞中转染小鼠或人IFN-β表达质粒后外源表达的IFN-β的分泌极性:人大肠癌Caco-2、小鼠鳞状细胞癌Pam-T、犬肾MDCK、猪肾小管上皮细胞LLC-PK 1在前三种中,瞬时表达的IFN-β主要从进行转染的细胞膜侧分泌;如果将质粒应用于上室或下室,则IFN-β分别从顶膜或基底外侧膜分泌。有趣的是,从两侧同时转染,顶部用小鼠IFN-β基因和底部用人IFN-β基因,导致小鼠IFN-β分泌到上部隔室中,而人IFN-β分泌到下部隔室中,反之亦然。LLC-PK_1细胞呈非极性瞬时分泌。同时,从用IFN-β表达质粒转染的任一细胞系建立的转化体的稳定分泌是非极化的。综合这些结果表明,上皮细胞有不同的蛋白分选分泌途径相同的蛋白质。分选方式似乎取决于蛋白质的表达方式,组成型或突现型。这些结果将有助于构建基因转移到肠上皮细胞和其他极化细胞的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshinobu, Takakura: "Cellular uptake properties of oligonucleotides in LLC-PK_1 renal epithelial cells." Antisense and Nucleic Acid Drug Development. 8. 67-73 (1998)
Yoshinobu, Takakura:“LLC-PK_1 肾上皮细胞中寡核苷酸的细胞摄取特性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sachiko, Okamoto: "Stimulation side-dependent asymmetrical secretion of poly C-induced interferon-β from polarized epithelial cell lines" Biochemical and Biophysical Research Communications. 254. 5-9 (1999)
Sachiko,Okamoto:“从极化上皮细胞系刺激多聚 C 诱导的干扰素-β 的侧依赖性不对称分泌”《生物化学和生物物理研究通讯》254. 5-9 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taro Kanamaru: "Biological effects and cellular uptake c-myc antisense oligonucleotides and their cationic liposome complexes." Jourmal of Drug Targeting. 5(4). 235-246 (1998)
Taro Kanamaru:“c-myc 反义寡核苷酸及其阳离子脂质体复合物的生物效应和细胞摄取。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taro, Kanamaru: "Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes." Journal of Drug Targeting. 5(4). 235-246 (1998)
Taro, Kanamaru:“c-myc 反义寡核苷酸及其阳离子脂质体复合物的生物效应和细胞摄取。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshinobu Takakura: "Cellular uptake properties of oligonucleotides in LLC-PK_1 renal epithelial cells." Antisense and Nucleic Acid Drug Development. (in press).
Yoshinobu Takakura:“LLC-PK_1 肾上皮细胞中寡核苷酸的细胞摄取特性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAKURA Yoshinobu其他文献

TAKAKURA Yoshinobu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAKURA Yoshinobu', 18)}}的其他基金

Optimization of cytokine gene therapy based on the regulation of transcription/translation, pharmacokinetics, and cellular response.
基于转录/翻译、药代动力学和细胞反应调节的细胞因子基因治疗的优化。
  • 批准号:
    24390008
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Design and delivery of plasmid vector for spatiotemporal control of the expression of therapeutic protein and siRNA
用于时空控制治疗蛋白和 siRNA 表达的质粒载体的设计和递送
  • 批准号:
    21390009
  • 财政年份:
    2009
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of all inclusive anti tumor immunotherapy based on engineered protein and nucleic acid
基于工程蛋白和核酸的全包式抗肿瘤免疫疗法的开发
  • 批准号:
    19390041
  • 财政年份:
    2007
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Design and delivery of nucleic acid drugs for optimization of DNA vaccination
用于优化 DNA 疫苗接种的核酸药物的设计和递送
  • 批准号:
    17390041
  • 财政年份:
    2005
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of novel delivery strategies to dendritic cells and optimization of DNA vaccination
树突状细胞新型递送策略的建立和 DNA 疫苗接种的优化
  • 批准号:
    15390048
  • 财政年份:
    2003
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of plasmid DNA delivery methods to antigen presenting cells for optimized DNA vaccination
开发质粒 DNA 递送至抗原呈递细胞的方法,以优化 DNA 疫苗接种
  • 批准号:
    13470514
  • 财政年份:
    2001
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of local drug disposition analysis and delivery methods in human solid tumors
人类实体瘤局部药物分布分析和递送方法的开发
  • 批准号:
    12557212
  • 财政年份:
    2000
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
遺伝子医薬品の体内動態および細胞取り込み機構の解明に基づくデリバリー戦略の確立
阐明基因药物的药代动力学和细胞摄取机制,建立递送策略
  • 批准号:
    11672257
  • 财政年份:
    1999
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Delivery Systems for the Control of Pharmacokinetics and Intracellular Trafficking of Antisense Drugs
开发用于控制反义药物的药代动力学和细胞内运输的递送系统
  • 批准号:
    07672351
  • 财政年份:
    1995
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 2.43万
  • 项目类别:
SBIR Phase I: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
SBIR 第一期:用于新型 T 细胞免疫疗法的工程诱导胸腺上皮细胞
  • 批准号:
    2234041
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Standard Grant
Elucidation of switching mechanism in the Wnt pathway of human amniotic epithelial cells
阐明人羊膜上皮细胞Wnt通路的转换机制
  • 批准号:
    23K15421
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Structural diversity of ceramide moiety responsible for apical membrane function of bladder transitional epithelial cells
负责膀胱移行上皮细胞顶膜功能的神经酰胺部分的结构多样性
  • 批准号:
    23K08792
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
禁食诱导的小肠上皮细胞辐射防护机制
  • 批准号:
    10645872
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Epigenetic regulation of lineage specification in colon epithelial cells
结肠上皮细胞谱系规范的表观遗传调控
  • 批准号:
    10676682
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
Study of the instability among mutant epithelial cells, adjacent normal epithelial cells and stromal cells to develop strategies for screening and very early detection of cancer.
研究突变上皮细胞、邻近正常上皮细胞和基质细胞之间的不稳定性,以制定癌症筛查和极早期检测策略。
  • 批准号:
    23H03102
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Efficient, controlled delivery of synthetic anion carriers to epithelial cells for CFTR replacement therapy
高效、受控地将合成阴离子载体递送至上皮细胞,用于 CFTR 替代疗法
  • 批准号:
    2904232
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Studentship
MICA: Interrogating the functional impact of novel asthma genetic variants using genomics and inducible pluripotent stem cell-derived epithelial cells
MICA:利用基因组学和诱导多能干细胞衍生的上皮细胞探讨新型哮喘遗传变异的功能影响
  • 批准号:
    MR/X000974/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了